Industry Financials
How to evaluate financials of a company in the Pharma and biotechnology industry?
1. Revenue and Income: The first step in evaluating a pharma or biotech company's financials is to look at its revenue and income. This will give an overall picture of how well the company is performing financially. Look for consistent revenue growth over the past few years, along with net income that is positive and increasing.
2. Research and Development (R&D) Expenses: For pharma and biotech companies, a large portion of their revenue is often invested in research and development. Therefore, it is important to analyze the R&D expenses and track their trend over time. A high level of R&D spending may indicate a strong pipeline of drugs in development, but it can also be a sign of increased risk.
3. Patents and Intellectual Property: These are crucial for companies in the pharma and biotech industry as they protect their products from competitors. Assess the number of patents held by the company, their duration, and any upcoming expirations that may impact revenue.
4. Cash and Debt: Look at the company's balance sheet to assess its cash position and level of debt. A company with a strong cash balance and manageable debt burden is in a better financial position to weather any potential challenges.
5. Product Pipeline: It is essential to assess the company's product pipeline to determine the potential for future revenue. Evaluate the stage of development of each product, the likelihood of success, and the potential market size.
6. Marketing and Sales Expenses: Marketing and sales expenses are a significant component of a pharma or biotech company's financials. Analyze their expense trend and compare it to revenue growth to determine efficiency and effectiveness.
7. Competition: As with any industry, competition can have a significant impact on a pharma or biotech company's financials. Evaluate the competitive landscape, including key players, their products, and their market share.
8. Regulatory Environment: The pharma and biotech industry is highly regulated, and changes in regulations can have a significant impact on a company's financials. Stay updated on current and potential regulations and assess how they may affect the company's operations and financials.
9. Market Trends: Keep an eye on market trends in the pharma and biotech industry. This includes factors such as drug pricing, healthcare policies, and advancements in technology, which can impact a company's financial performance.
10. Management and Governance: Evaluate the company's leadership, their experience, and their track record in successfully bringing products to market. Good corporate governance practices are also important for the sustained success of a company.
What are the cost structures and profit margins in the Pharma and biotechnology industry?
The cost structure in the pharma and biotechnology industry is unique due to the high costs associated with research, development, and commercialization of new drugs and treatments. Below are some of the major cost components in this industry:
1. Research and Development (R&D) Costs: Developing new drugs and treatments involves extensive research and testing, which can be a significant cost for companies in this industry. R&D costs can include expenses related to clinical trials, laboratory equipment, and salaries of research personnel.
2. Marketing and Advertising Costs: Once a drug is approved, companies invest heavily in marketing and advertising to promote their products to healthcare professionals and consumers. This can include expenses such as advertising campaigns, sales teams, and physician education programs.
3. Manufacturing Costs: The production of pharmaceuticals and biotech products requires sophisticated manufacturing processes and high-quality facilities, resulting in significant costs for companies.
4. Regulatory and Compliance Costs: The pharmaceutical industry is highly regulated, and companies must adhere to strict regulatory requirements throughout the drug development process. This can result in significant costs related to regulatory submissions, compliance monitoring, and inspections.
5. Intellectual Property Costs: Companies in the pharma and biotech industry spend a considerable amount of money on acquiring and protecting patents for their products, which can be a significant cost component.
Profit margins in the pharma and biotech industry vary based on factors such as the success of new products, competition, and pricing strategies. However, research shows that the average profit margin for the pharmaceutical industry is around 16%, while for biotech companies, it can range from 0% to over 30%, depending on the stage of development of their products. Companies with blockbuster drugs or highly successful products usually have higher profit margins compared to those with a smaller product portfolio. Additionally, generic drug manufacturers tend to have lower profit margins due to higher competition and pricing pressure.
What is the size of the Pharma and biotechnology industry in terms of revenue and market share?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9udWREMEw2 a3V4VjhEV2xVdEpCOC53 ZWJwIiBhbHQ9IkdsYXhv U21pdGhLbGluZSIgdGl0 bGU9IkdsYXhvU21pdGhL bGluZSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdsYXhv U21pdGhLbGluZT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
How do fluctuations in input costs or external factors impact the Pharma and biotechnology industry economics?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9udWREMEw2 a3V4VjhEV2xVdEpCOC53 ZWJwIiBhbHQ9IkdsYXhv U21pdGhLbGluZSIgdGl0 bGU9IkdsYXhvU21pdGhL bGluZSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdsYXhv U21pdGhLbGluZT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What are the big costs in the Pharma and biotechnology industry?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9udWREMEw2 a3V4VjhEV2xVdEpCOC53 ZWJwIiBhbHQ9IkdsYXhv U21pdGhLbGluZSIgdGl0 bGU9IkdsYXhvU21pdGhL bGluZSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdsYXhv U21pdGhLbGluZT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What was the average P/E ratio at the Pharma and biotechnology industry in the recent years?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9udWREMEw2 a3V4VjhEV2xVdEpCOC53 ZWJwIiBhbHQ9IkdsYXhv U21pdGhLbGluZSIgdGl0 bGU9IkdsYXhvU21pdGhL bGluZSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdsYXhv U21pdGhLbGluZT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What was the average Dividend Payout Ratio ratio at the Pharma and biotechnology industry in the recent years?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9udWREMEw2 a3V4VjhEV2xVdEpCOC53 ZWJwIiBhbHQ9IkdsYXhv U21pdGhLbGluZSIgdGl0 bGU9IkdsYXhvU21pdGhL bGluZSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdsYXhv U21pdGhLbGluZT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What was the average Return on Sales ratio at the Pharma and biotechnology industry in the recent years?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9udWREMEw2 a3V4VjhEV2xVdEpCOC53 ZWJwIiBhbHQ9IkdsYXhv U21pdGhLbGluZSIgdGl0 bGU9IkdsYXhvU21pdGhL bGluZSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdsYXhv U21pdGhLbGluZT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What was the average Return on Assets ratio at the Pharma and biotechnology industry in the recent years?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9udWREMEw2 a3V4VjhEV2xVdEpCOC53 ZWJwIiBhbHQ9IkdsYXhv U21pdGhLbGluZSIgdGl0 bGU9IkdsYXhvU21pdGhL bGluZSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdsYXhv U21pdGhLbGluZT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What was the average Return on Equity ratio at the Pharma and biotechnology industry in the recent years?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9udWREMEw2 a3V4VjhEV2xVdEpCOC53 ZWJwIiBhbHQ9IkdsYXhv U21pdGhLbGluZSIgdGl0 bGU9IkdsYXhvU21pdGhL bGluZSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdsYXhv U21pdGhLbGluZT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What was the average Gross Margin at the Pharma and biotechnology industry in the recent years?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9udWREMEw2 a3V4VjhEV2xVdEpCOC53 ZWJwIiBhbHQ9IkdsYXhv U21pdGhLbGluZSIgdGl0 bGU9IkdsYXhvU21pdGhL bGluZSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdsYXhv U21pdGhLbGluZT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What was the average Operating Margin at the Pharma and biotechnology industry in the recent years?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9udWREMEw2 a3V4VjhEV2xVdEpCOC53 ZWJwIiBhbHQ9IkdsYXhv U21pdGhLbGluZSIgdGl0 bGU9IkdsYXhvU21pdGhL bGluZSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEdsYXhv U21pdGhLbGluZT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
